Patent · US Active

Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists

US8048874B2 · kind B2 · utility

9Cited by

25References

22Claims

0Family size

Assignee

Azevan Pharmaceuticals, Inc. · US

Inventors

Gary A. Koppel · Indianapolis, US
Marvin J. Miller · South Bend, US

Key dates

Filing date	Jul 18, 2006
Grant date	Nov 1, 2011
Priority date	—
Expiry date	May 26, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted 2-(azetidin-2-on-1-yl)alkoxyalkylalkanoic acids and 2-(azetidin-2-on-1-yl)arylalkylalkanoic acids, and analogs and derivatives thereof are described. Methods for using the described compounds, and pharmaceutical compositions thereof, to treat disease states responsive to antagonism of one or more vasopressin receptors are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.